The Riverside Company, a global private investor focused on the smaller end of the middle market, has added Medical Marketing Solutions Group (MMSG) to its Red Nucleus platform.
MMSG is a leading provider of strategic services, scientific and medical communications, and operational and event management services to global biopharmaceutical companies.
MMSG marks the sixth add-on Riverside has completed to Red Nucleus since its initial investment in December 2019. Red Nucleus has grown rapidly and earned a reputation as a leading provider of commercialisation, medical communications and learning & development services for top global biopharma clients.
